Madrigal Pharmaceuticals Inc (NASDAQ: MDGL) — Healthcare · Share Price, Chart & Market Data
About: Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company was founded in 2016 and is headquartered in West Conshohocken, Pennsylvania.
Sector: Healthcare
Industry: Biotechnology
Latest price: $518.58 (+0.37%)
MDGLMadrigal Pharmaceuticals Inc
Loading watchlist status…
Trade MDGL now
Madrigal Pharmaceuticals Inc share price
MDGL price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
30 Apr, 4:12 am GMT+0
MDGL price performance
-0.031%
5D
2.62%
1M
-12.678%
YTD
52.165%
1Y
MDGL price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
NASDAQ rank
N/A
Sector Rank
N/A
Delayed
30 Apr, 4:12 am GMT+0
MDGL details
MDGL Market Signals